Evidence map›Paper›PMID 37593172›Full record

ArticleFrontiers in pharmacology2023

Study of the antioxidant and anti-pancreatic cancer activities of

Ziad Chebaro, Rola Abdallah, Adnan Badran, Kamar Hamade, Akram Hijazi, Marc Maresca, Joelle Edward Mesmar, Elias Baydoun

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Isolation and Identification of Chemical Compounds fromMolecules (Basel, Switzerland) · 2023
    Article
  2. Ethnopharmacology and therapeutic potential ofFrontiers in pharmacology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Ziad ChebaroPlatforme de Recherche et D'analyse en Sciences de L'environnement (EDST-PRASE), Beirut, Lebanon.
Rola AbdallahDepartment of Biology, American University of Beirut, Beirut, Lebanon.
Adnan BadranDepartment of Nutrition, University of Petra, Amman, Jordan.
Kamar HamadeUMRT INRE 1158 BioEcoAgro, Laboratorie BIOPI, University of Picardie Jules Verne, Amiens, France.
Akram HijaziPlatforme de Recherche et D'analyse en Sciences de L'environnement (EDST-PRASE), Beirut, Lebanon.
Marc MarescaAix-Marseille Univ, CNRS, Centrale Marseille, iSM2, Marseille, France.
Joelle Edward MesmarDepartment of Biology, American University of Beirut, Beirut, Lebanon.
Elias BaydounDepartment of Biology, American University of Beirut, Beirut, Lebanon.
American University of Beirut · LBBiologie des Plantes et Innovation · FRCentre National de la Recherche Scientifique · FRPetra University · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer is a highly aggressive malignancy and a leading cause of cancer-related deaths worldwide. Moreover, the incidence and mortality rates for pancreatic cancer are projected to keep increasing. A major challenge in the treatment of pancreatic cancer is the lack of effective screening approaches, which contributes to its poor prognosis, indicating the need for new treatment regimens and alternative therapies, such as herbal medicine. The medicinal plant

Indexed as

Anchusa strigosaapoptosisbioactive compoundsconventional extractionCOX-2herbal medicinepancreatic cancerultrasound-assisted extraction

Identifiers

PMID37593172
PMCPMC10427766
OpenAlexW4385460962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.